Brief: Alkem Laboratories Approves Transfer Of Trade Generics Business To Alkem Wellness
Dec 10 (Reuters) - Alkem Laboratories Ltd ALKE.NS :
* APPROVES TRANSFER OF TRADE GENERICS BUSINESS TO ALKEM
WELLNESS
* CONSIDERATION EXPECTED TO BE UP TO 7.50 BILLION RUPEES
Source text: ID:nBSE1ZqG4j
Further company coverage: ALKE.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alkem Laboratories
See all newsBrief: Alkem Labs Approved Initiation Of Forensic Audit In Connection With Recent Incident Involving Alleged Misappropriation Of Funds By A Former Employee
Brief: Alkem Labs Launches Neuceno (Cenobamate) For Treatment Of Partial-Onset Seizures In Adult Patients
Brief: Alkem Labs Launches Renocia Exo, Ginsenoside Exosome-Based Hair Growth Serum
Brief: Alkem Labs Board Approves Investment Of Up To 750 Million Rupees For New Block At Baddi Manufacturing Facility
Brief: Alkem Laboratories Q1 Consol Revenue From Operations 37.4 Billion Rupees